Cencora (COR) beats earnings and revenue estimates, positive news.

From Nasdaq: 2024-11-06 07:45:02

Cencora (COR) reported quarterly earnings of $3.34 per share, surpassing the Zacks Consensus Estimate of $3.21. This represents a 4.05% earnings surprise and an increase from $2.86 per share a year ago. The company’s revenue for the quarter came in at $79.05 billion, exceeding expectations by 1.76%.

Cencora’s stock performance has been positive, with a 13.9% gain this year compared to the S&P 500’s 21.2% increase. Investors are now looking to the company’s earnings outlook and management’s commentary for future guidance on stock movement.

Embecta Corp. (EMBC), another player in the medical services industry, is expected to report quarterly earnings of $0.40 per share, down 32.2% from the previous year. Revenue is forecasted at $279.14 million, showing a 1% decline from the year-ago quarter.

Research Chief names a top stock pick with potential to double in value, targeting millennial and Gen Z audiences. The company generated nearly $1 billion in revenue last quarter and presents a promising investment opportunity. Investors can access more stock recommendations from Zacks Investment Research for potential high returns.



Read more at Nasdaq: Cencora (COR) Tops Q4 Earnings and Revenue Estimates